Literature DB >> 18628462

Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.

William J Cottrell1, Anne D Paquette, Kenneth R Keymel, Thomas H Foster, Allan R Oseroff.   

Abstract

PURPOSE: In superficial basal cell carcinomas treated with photodynamic therapy with topical delta-aminolevulinic acid, we examined effects of light irradiance on photodynamic efficiency and pain. The rate of singlet-oxygen production depends on the product of irradiance and photosensitizer and oxygen concentrations. High irradiance and/or photosensitizer levels cause inefficient treatment from oxygen depletion in preclinical models. EXPERIMENTAL
DESIGN: Self-sensitized photobleaching of protoporphyrin IX (PpIX) fluorescence was used as a surrogate metric for photodynamic dose. We developed instrumentation measuring fluorescence and reflectance from lesions and margins during treatment at 633 nm with various irradiances. When PpIX was 90% bleached, irradiance was increased to 150 mW/cm(2) until 200 J/cm(2) were delivered. Pain was monitored.
RESULTS: In 33 superficial basal cell carcinomas in 26 patients, photobleaching efficiency decreased with increasing irradiance above 20 mW/cm(2), consistent with oxygen depletion. Fluences bleaching PpIX fluorescence 80% (D80) were 5.7 +/- 1.6, 4.5 +/- 0.3, 7.5 +/- 0.8, 7.4 +/- 0.3, 12.4 +/- 0.3, and 28.7 +/- 7.1 J/cm(2), respectively, at 10, 20, 40, 50, 60 and 150 mW/cm(2). At 20-150 mW/cm(2), D80 doses required 2.5-3.5 min; times for the total 200 J/cm(2) were 22.2-25.3 min. No significant pain occurred up to 50 mW/cm(2); pain was not significant when irradiance then increased. Clinical responses were comparable to continuous 150 mW/cm(2) treatment.
CONCLUSIONS: Photodynamic therapy with topical delta-aminolevulinic acid using approximately 40 mW/cm(2) at 633 nm is photodynamically efficient with minimum pain. Once PpIX is largely photobleached, higher irradiances allow efficient, rapid delivery of additional light. Optimal fluence at a single low irradiance is yet to be determined.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628462      PMCID: PMC2810858          DOI: 10.1158/1078-0432.CCR-07-5199

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  34 in total

1.  Analytical model for extracting intrinsic fluorescence in turbid media.

Authors:  J Wu; M S Feld; R P Rava
Journal:  Appl Opt       Date:  1993-07-01       Impact factor: 1.980

2.  A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy.

Authors:  Ken Kang-Hsin Wang; Soumya Mitra; Thomas H Foster
Journal:  Med Phys       Date:  2007-01       Impact factor: 4.071

Review 3.  5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research.

Authors:  Q Peng; K Berg; J Moan; M Kongshaug; J M Nesland
Journal:  Photochem Photobiol       Date:  1997-02       Impact factor: 3.421

4.  The cutaneous uptake of atmospheric oxygen contributes significantly to the oxygen supply of human dermis and epidermis.

Authors:  M Stücker; A Struk; P Altmeyer; M Herde; H Baumgärtl; D W Lübbers
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

5.  Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser Doppler perfusion imaging.

Authors:  I Wang; S Andersson-Engels; G E Nilsson; K Wårdell; K Svanberg
Journal:  Br J Dermatol       Date:  1997-02       Impact factor: 9.302

6.  Pain caused by photodynamic therapy of skin cancer.

Authors:  S Grapengiesser; M Ericson; F Gudmundsson; O Larkö; A Rosén; A-M Wennberg
Journal:  Clin Exp Dermatol       Date:  2002-09       Impact factor: 3.470

7.  Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.

Authors:  B W Henderson; T M Busch; L A Vaughan; N P Frawley; D Babich; T A Sosa; J D Zollo; A S Dee; M T Cooper; D A Bellnier; W R Greco; A R Oseroff
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

8.  A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage.

Authors:  A M Soler; T Warloe; A Berner; K E Giercksky
Journal:  Br J Dermatol       Date:  2001-09       Impact factor: 9.302

Review 9.  Photodynamic therapy for nonmelanoma skin cancers. Current review and update.

Authors:  Nathalie C Zeitouni; Allan R Oseroff; Sherry Shieh
Journal:  Mol Immunol       Date:  2003-07       Impact factor: 4.407

10.  Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry.

Authors:  B Newell; A J Bedlow; S Cliff; S B Drysdale; A W B Stanton; P S Mortimer
Journal:  Br J Dermatol       Date:  2003-07       Impact factor: 9.302

View more
  28 in total

1.  A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer.

Authors:  Nathalie C Zeitouni; Ulas Sunar; Daniel J Rohrbach; Anne D Paquette; David A Bellnier; Yi Shi; Gregory Wilding; Thomas H Foster; Barbara W Henderson
Journal:  Dermatol Surg       Date:  2014-12       Impact factor: 3.398

Review 2.  Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.

Authors:  Harry Quon; Craig E Grossman; Jarod C Finlay; Timothy C Zhu; Clarice S Clemmens; Kelly M Malloy; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2011-06       Impact factor: 3.631

3.  Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.

Authors:  Theresa M Busch; Xiaoman Xing; Guoqiang Yu; Arjun Yodh; E Paul Wileyto; Hsing-Wen Wang; Turgut Durduran; Timothy C Zhu; Ken Kang-Hsin Wang
Journal:  Photochem Photobiol Sci       Date:  2009-10-15       Impact factor: 3.982

4.  Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic Therapy.

Authors:  Shannon M Gallagher-Colombo; Harry Quon; Kelly M Malloy; Peter H Ahn; Keith A Cengel; Charles B Simone; Ara A Chalian; Bert W O'Malley; Gregory S Weinstein; Timothy C Zhu; Mary E Putt; Jarod C Finlay; Theresa M Busch
Journal:  Photochem Photobiol       Date:  2015-07-02       Impact factor: 3.421

5.  Effect of light polarization on the efficiency of photodynamic therapy of basal cell carcinomas: an in vitro cellular study.

Authors:  M JalalKamali; S N Nematollahi-Mahani; M Shojaei; A Shamsoddini; N Arabpour
Journal:  Lasers Med Sci       Date:  2017-11-15       Impact factor: 3.161

6.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Seonkyung Lee; Dieter Manstein; Stefan Elrington; Garuna Kositratna; David Schoenfeld; Brian Pogue; Steven J Davis; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

7.  Aminolevulinic acid-photodynamic therapy combined with topically applied vascular disrupting agent vadimezan leads to enhanced antitumor responses.

Authors:  Allison Marrero; Theresa Becker; Ulas Sunar; Janet Morgan; David Bellnier
Journal:  Photochem Photobiol       Date:  2011-06-13       Impact factor: 3.421

8.  A light emitting diode (LED) based spatial frequency domain imaging system for optimization of photodynamic therapy of nonmelanoma skin cancer: quantitative reflectance imaging.

Authors:  R B Saager; D J Cuccia; S Saggese; K M Kelly; A J Durkin
Journal:  Lasers Surg Med       Date:  2013-04       Impact factor: 4.025

9.  Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model.

Authors:  K E Wright; E Liniker; M Loizidou; C Moore; A J Macrobert; J B Phillips
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

Review 10.  Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.

Authors:  Christine B Warren; Laszlo J Karai; Allison Vidimos; Edward V Maytin
Journal:  J Am Acad Dermatol       Date:  2009-12       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.